List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5 studies with search of:   "Immuno-US" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Biological: gp160 Vaccine (Immuno-AG);   Drug: Stavudine;   Drug: Didanosine
2 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Condition: HIV Infections
Interventions: Biological: gp160 Vaccine (Immuno-AG);   Biological: Hepatitis B Vaccine (Recombinant)
3 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (Immuno-AG)
4 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-Mcg Dose
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (Immuno-AG)
5 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (Immuno-AG)

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options